Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.008 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.67 | 0.01 |